1. Prevalence, incidence and residual risk of transfusion-transmitted hepatitis C virus and human immunodeficiency virus after the implementation of nucleic acid testing in Italy: a 7-year (2009–2015) survey;Velati;Blood Transfus,2018
2. Evolution of the residual risk of HBV, HCV and HIV transmission through blood transfusion in the Region of Valencia, Spain, during a 15-year period (2003–2017);López-Menchero;Blood Transfus,2019
3. Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services;O’Brien;Vox Sang,2012
4. Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios;Bruhn;Transfusion,2013
5. Selection strategies for newly registered blood donors in European countries;Lieshout-Krikke;Blood Transfus,2017